Tsung-Wei Chen Selected Research

Colorectal Neoplasms (Colorectal Cancer)

7/2022	Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade.
1/2021	ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer.
2/2020	Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer.
1/2019	Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan.
1/2018	HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsung-Wei Chen Research Topics

Disease

14	Neoplasms (Cancer) 07/2022 - 01/2017
9	Rectal Neoplasms (Rectal Cancer) 07/2022 - 11/2016
5	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
2	Infections 01/2019 - 01/2019
1	Bites and Stings (Sting) 07/2022
1	Adenocarcinoma 07/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Enteropathy-Associated T-Cell Lymphoma 01/2022
1	Ulcerative Colitis 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2021
1	Uremia 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Hyperkalemia 01/2021
1	Carcinoma (Carcinomatosis) 12/2020
1	Hemorrhage 01/2020
1	Lymphatic Metastasis 02/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Follicular Adenocarcinoma 01/2017

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 07/2022 - 02/2019
3	B7-H1 AntigenIBA 01/2022 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	LigandsIBA 12/2020 - 10/2018
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 10/2021 - 01/2021
2	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 01/2021 - 01/2020
2	HMGB1 Protein (HMG1)IBA 04/2018 - 01/2018
1	Interferon Type IIBA 07/2022
1	5- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2022
1	Pattern Recognition ReceptorsIBA 10/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2021
1	Decitabine FDA Link 02/2020
1	DNA (Deoxyribonucleic Acid)IBA 02/2020
1	MethyltransferasesIBA 02/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Calcibiotic Root Canal SealerIBA 01/2019
1	GoldIBA 01/2019
1	Dynamins (Dynamin)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Thyroglobulin FDA Link 01/2017
1	RacivirIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Thyroid Nuclear Factor 1IBA 01/2017
1	IodineIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Capecitabine (Xeloda)FDA Link 11/2016

Therapy/Procedure

7	Neoadjuvant Therapy 10/2021 - 01/2018
6	Drug Therapy (Chemotherapy) 07/2022 - 11/2016
3	Therapeutics 07/2022 - 01/2017
3	Chemoradiotherapy 10/2021 - 11/2016
2	Radiotherapy 07/2022 - 04/2019
2	Adjuvant Chemotherapy 07/2022 - 01/2021
1	Transplantation 01/2021
1	Precision Medicine 05/2020
1	Immunotherapy 02/2020
1	Thyroidectomy 01/2017